Thomas A. Collet
Gründer bei Phrixus Pharmaceuticals, Inc.
Profil
Thomas A.
Collet is the founder of Phrixus Pharmaceuticals, Inc. (founded in 2006) where he currently holds the title of President, Chief Executive Officer & Director.
He is also the founder of Neural Intervention Technologies, Inc. (founded in 2005) and Meditrina Pharmaceuticals, Inc. (founded in 2006).
At Meditrina Pharmaceuticals, Inc., he held the title of President & Chief Executive Officer from 2009 to 2010.
Dr. Collet's current job is at Bilayer Therapeutics, Inc. (since 2020) where he is the President, Chief Executive Officer & Director.
His former jobs include being the President, Chief Executive Officer & Director at Rubicon Genomics, Inc., Sierra Oncology, Inc., and Monsanto Co. He also worked as a Vice President-Business Development at Monsanto Co., an Engagement Manager at McKinsey & Co., Inc., and a General Partner at Tullis Health Investors, Inc.Dr. Collet obtained a doctorate degree from the Massachusetts Institute of Technology.
Aktive Positionen von Thomas A. Collet
| Unternehmen | Position | Beginn |
|---|---|---|
Phrixus Pharmaceuticals, Inc.
 Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Gründer | 17.07.2012 |
Bilayer Therapeutics, Inc.
 Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | Vorstandsvorsitzender | 01.08.2020 |
Ehemalige bekannte Positionen von Thomas A. Collet
| Unternehmen | Position | Ende |
|---|---|---|
Tullis Health Investors, Inc.
 Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Rubicon Genomics, Inc.
 Rubicon Genomics, Inc. Medical SpecialtiesHealth Technology Rubicon Genomics, Inc. engages in the provision of pre-analytical amplification technologies. The firm specializes in enzymology, nucleic acid chemistry, sample processing and manufacturing. The company was founded by Dr. John Langmore and Vladimir Makarov in 2000 and is headquartered in Ann Arbor, MI. | Vorstandsvorsitzender | - |
| SIERRA ONCOLOGY, INC. | Vorstandsvorsitzender | - |
Neural Intervention Technologies, Inc.
 Neural Intervention Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Neural Intervention Technologies, Inc. manufactures medical services. The company was founded by Daryl Kipke and Thomas A. Collet on September 12, 2005 and is headquartered in Ann Harbor, MI. | Gründer | - |
Ausbildung von Thomas A. Collet
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
Rubicon Genomics, Inc.
Rubicon Genomics, Inc. Medical SpecialtiesHealth Technology Rubicon Genomics, Inc. engages in the provision of pre-analytical amplification technologies. The firm specializes in enzymology, nucleic acid chemistry, sample processing and manufacturing. The company was founded by Dr. John Langmore and Vladimir Makarov in 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Phrixus Pharmaceuticals, Inc.
Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Tullis Health Investors, Inc.
Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida. | Finance |
Neural Intervention Technologies, Inc.
Neural Intervention Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Neural Intervention Technologies, Inc. manufactures medical services. The company was founded by Daryl Kipke and Thomas A. Collet on September 12, 2005 and is headquartered in Ann Harbor, MI. | Electronic Technology |
Meditrina Pharmaceuticals, Inc.
 Meditrina Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meditrina Pharmaceuticals, Inc. operated as a clinical-stage pharmaceutical company that develops and commercializes medical therapies that threat women's reproductive system disorders, with a focus on gynecological and aromatase-mediated conditions with serious unmet medical needs such as endometriosis and uterine fibroids. The company was founded by Thomas A. Collet and Holly Vene in 2006 and was headquartered in Ann Arbor, MI. | Health Technology |
Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | Health Technology |
